Antitumor agent-53
Antitumor agent-53 is a potent antitumor agent. Antitumor agent-53 induces cell cycle arrest at the G2/M phase. Antitumor agent-53 inhibits the PI3K/AKT pathway to induce the apoptosis of HGC-27 cells. Antitumor agent-53 has the potential for the research of gastrointestinal tumors[1].
Product Specifications
CAS Number
2757145-67-6
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/antitumor-agent-53.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=C(N(C3C4=C(C5=CC=CC=C5N4)CCN13)C6=CC=CC(F)=C6)C=CC=C2
Molecular Formula
C24H18FN3O
Molecular Weight
383.42
References & Citations
[1]Hao X, et al. Design, synthesis and bioactivity evaluation of novel N-phenyl-substituted evodiamine derivatives as potent anti-tumor agents. Bioorg Med Chem. 2021; 55:116595.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BZ48855 1 Vial
PCMV-3xFLAG-TNFAIP3 (human) -Y614A-F615A-F770A-G771A
Sign In for Pricing
View Details 
GTR15174340 1 Vial
Lentiviral mouse Ccl3 shRNA (UAS) - Lentiviral mouse Ccl3 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details GTR15133629 1 Vial
Lentiviral human CXXC5 shRNA (UAS) - Lentiviral human CXXC5 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 
orb3166815 200 µL
Holothuria glaberrima Insulin-like growth factor Antibody Fluoro594 Conjugated
Sign In for Pricing
View Details